Patient Organisations

The MetabERN Patient Board represents the voice of patients affected by inherited metabolic disorders. With their experience they will help healthcare providers tailor medical advances to patient’s needs.

Education on IMDs

The Diagnostic, Clinical and Therapeutic Education Programme (DCTEP) on Inherited Metabolic Disorders (IMDs) is the first e-learning course developed by the MetabERN network and accredited by the European Accreditation Council for Continuing Medical Education (EACCME).

In solidarity with Ukraine and Ukrainian rare metabolic disease patients

In solidarity with the Ukrainian people, including Ukrainian rare metabolic patients, MetabERN centres, especially in neighbouring countries, are keen and ready to provide medical services for patients suffering from rare metabolic diseases.

MatabERN

Annual Board Meeting 2024 Budapest

27 – 29 November

What is MetabERN ?

European Reference Networks (ERN) are networks connecting healthcare providers, health care professionals and patients across Europe. They aim to tackle complex or rare diseases and conditions which require highly specialised treatment and a pooling of knowledge and resources. 24 ERNs were launched in 2017, involving more than 900 highly specialised healthcare teams, located in more than 300 hospitals in 29 European countries.

MetabERN Poster e1731431114465

MetabERN is one of the 24 ERNs that focuses on Inherited Metabolic Diseases. It is a network of specialised reference centres established by the EU to facilitate access to the best available care and address the needs across the border of all patients and their families affected by inherited metabolic rare diseases (IMDs).
MetabERN provides a platform for the exchange of best practices, the development of clinical guidelines, and the facilitation of cross-border healthcare for patients with rare metabolic diseases.

94

Medical Centres

29

Countries

39

Patient
Associations

900+

Healthcare Professionals

94

Medical Centres

29

Countries

39

Patient Organisations

3000+

Healthcare Professionals

For Patients

Patient Board

The Patient Board consists of patient organisations that are involved in IMDs from across Europe, and collaborates with Healthcare Professionals

Patient Activities

Find out and get involved in activities carried out by our patient associations.

Patient Organisations

International and European patient organisations

Patient Resources

Resources for People Living with an IMD and their families

Cross – Border Healthcare

Seeking Healthcare in another EU member state: your lights

Activities

dctep 1

Educational activities and training opportunities on IMDs across Europe

Scientific Publications

Development of new clinical practice resources and dissemination of the existing knowledge

cpms


Virtual consultations among experts throughout Europe for challenging IMD cases

U IMD registry 344x258 1


Unified European Registry for Inherited Metabolic Disorders (U-IMD), the official patient registry of MetabERN

map 341x532 1

MetabERN subnetworks

Considering the complexity of this field, inherited metabolic diseases are divided into 7 disease-specific subgroups that are the basis of MetabERN Subnetworks.
PM MD

Disorders of pyruvate metabolism, Krebs cycle defects, mitochondrial oxidative phosphorylation disorders, disorders of thiamine transport and metabolism (PM-MD)

AOA

Aminoacid and organic acids related disorders (AOA)

LSD

Lysosomal storage disorders (LSD)

cfao

Carbohydrate, fatty acid oxidation and ketone bodies disorders
(C-FAO)

PD 1

Peroxisomal and lipid-related disorders (PD)

CDG 1

Congenital disorders of glycosylation and disorders of intracellular trafficking (CDG)

Immagini SNW 344 x 258

Disorders of neuromodulators and other small molecules (NOMS)

Hey, want to upgrade to pro plan?

18748

Upgrade Now

& get 25% off

Offer valid only for 24 hrs.

18749
Scroll to Top